DUBLIN--(BUSINESS WIRE)--The "Global Parkinson's Disease Epidemiology and Patient Flow Analysis - 2018" report has been added to ResearchAndMarkets.com's offering.
The research provides insights into Parkinson's Disease epidemiology, Parkinson's Disease diagnosed patients, and Parkinson's Disease treatment rate for US, Japan, and EU5 countries. The research measures key indicators including prevalence of Parkinson's Disease derived from epidemiological analysis, patients diagnosed with Parkinson's Disease, and patients treated with a drug therapy.
The research study helps executives estimate Parkinson's Disease market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.
The research provides estimates and forecasts of Parkinson's Disease prevalence, Parkinson's Disease diagnosis rate, and Parkinson's Disease treatment rate for the period 2017-2026. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan.
Key Topics Covered
1. Parkinson's Disease: Disease Definition
2. Global Parkinson's Disease Patient Flow
3. Parkinson's Disease Patient Flow in the US
4. Parkinson's Disease Patient Flow in Europe
5. Parkinson's Disease Patient Flow in Germany
6. Parkinson's Disease Patient Flow in France
7. Parkinson's Disease Patient Flow in Spain
8. Parkinson's Disease Patient Flow in Italy
9. Parkinson's Disease Patient Flow in UK
10. Parkinson's Disease Patient Flow in Japan
11. Research Methodology
For more information about this report visit https://www.researchandmarkets.com/research/rdxj64/parkinsons?w=4
